Studies about Inflammatory bowel disease (IBD) showed that overexpressing miR-146a inhibited TNF receptor-associated factor 6 (TRAF6) and IL-1 receptor-associated kinase 1 (IRAK1) expression in TNBS-induced colitis of rats. This evidence concerns the gene TRAF6 and colitis.